Arthritis, Psoriatic: all 594 studies

Page 6 of 6. Open to participants first (132), then studies with results posted, then the rest; newest registration first within each.

• Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisCompletedNCT02922192
• Effects of Weight-loss Treatment in Obese Patients With Psoriatic ArthritisCompletedNCT02917434Not applicable
• Stepping Up For Inflammatory ArthritisCompletedNCT02912221Not applicable
• C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in FranceCompletedNCT02886689
• A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The NetherlandsCompletedNCT02875184
• Effect of Secukinumab in the Treatment of Psoriatic ArthritisCompletedNCT02854163Phase 2
• Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic ArthritisCompletedNCT02849795Not applicable
• Thermography in Assessing Treatment Response to Golimumab in Psoriatic ArthritisTerminatedNCT02841176Not applicable
• Distal Erosions and Nail PsoriasisStatus unknownNCT02813720
• UCB Cimzia Pregnancy Follow-up StudyTerminatedNCT02775656
• Apremilast Pregnancy Exposure RegistryActive, not recruitingNCT02775500
• This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisCompletedNCT02772601Phase 1
• MYL-1401A Efficacy and Safety Comparability Study to Humira®CompletedNCT02714322Phase 3
• A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic ArthritisWithdrawnNCT02671188Phase 1
• A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic ArthritisCompletedNCT02627768
• Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic ArthritisCompletedNCT02598739Not applicable
• Treatment With Apremilast in Patients With Psoriatic ArthritisWithdrawnNCT02558361Phase 4
• Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.CompletedNCT02556034
• Psoriasis-Arthritis & Bone ProgramCompletedNCT02483234Phase 2
• Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic ArthritisWithdrawnNCT02475304Phase 2
• Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy StudyWithdrawnNCT02472717Phase 2
• A Study in Participants With Psoriatic Arthritis Attending Dermatology ClinicsCompletedNCT02470481
• Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
• Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?CompletedNCT02436785Not applicable
• A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197TerminatedNCT02429895Phase 2
• DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsACompletedNCT02413749
• Follow-up of Person-centered Care of Young Adults With Rheumatic DiseaseCompletedNCT02402894
• PBR28 PET and Inflammatory ArthritisCompletedNCT02361385
• A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic ArthritisCompletedNCT02267642Phase 2
• Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort StudyCompletedNCT02232321Not applicable
• Metformin in Psoriatic ArthritisCompletedNCT02188654Not applicable
• Effect of Exercise and Diet on Psoriatic ArthritisCompletedNCT02188641Not applicable
• Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?CompletedNCT02164214Phase 3
• The NOR-SWITCH StudyCompletedNCT02148640Phase 4
• Multiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisCompletedNCT02141763Phase 1
• 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes ActivityStatus unknownNCT02134613Phase 2
• Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisStatus unknownNCT02132234Phase 4
• Physiotherapy-led Outpatient Clinic for Patients With SpondyloarthritisCompletedNCT02098694Not applicable
• A Phase 3 Clinical Study of KHK 4827CompletedNCT02052609Phase 3
• A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial InvolvementCompletedNCT01969188
• Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic ArthritisStatus unknownNCT01939132Phase 4
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into SpanishStatus unknownNCT01891903
• Initial Treatment With Golimumab in Early PsACompletedNCT01871649Phase 3
• Employment and Arthritis: Making it WorkActive, not recruitingNCT01852851Not applicable
• Functional Limitations Due To The Foot Involvement In SpondyloarthritisCompletedNCT01833468
• OTIS Cimzia Pregnancy RegistryActive, not recruitingNCT01797224
• Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαTerminatedNCT01694264Phase 3
• Psoriatic Arthritis Treat to Target vs. Usual CareWithdrawnNCT01692912Not applicable
• A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisWithdrawnNCT01692457
• PET/CT in Psoriatic ArthritisCompletedNCT01654198
• Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic ArthritisCompletedNCT01559038
• HUmira in Psoriatic ArthritisCompletedNCT01465438Phase 4
• Web-based Support to Manage Arthritis PainCompletedNCT01463189Phase 2
• A Study of RO5310074 in Patients With Psoriatic ArthritisCompletedNCT01199809Phase 1
• Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic ArthritisCompletedNCT01139918
• National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker StudyCompletedNCT01123265
• TIght COntrol of Psoriatic ArthritisCompletedNCT01106079Phase 3
• Golimumab Safety and Surveillance Program Using the Ingenix NHI DatabaseCompletedNCT01081717
• Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical RoutineWithdrawnNCT01078610
• Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisCompletedNCT00998829
• A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic ArthritisCompletedNCT00963313
• To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00946686Phase 1
• Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic TreatmentCompletedNCT00902005
• Study Evaluating Anxiety and Depression in Patients With Psoriatic ArthritisCompletedNCT00884468
• Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in AustraliaCompletedNCT00751387
• Biologic Treatment Registry Across CanadaCompletedNCT00741793
• A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic ArthritisCompletedNCT00659412Phase 2
• Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
• Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic ArthritisCompletedNCT00646386Phase 2
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug TherapyCompletedNCT00646178Phase 3
• A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCompletedNCT00643526Early Phase 1
• Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic ArthritisCompletedNCT00580632
• Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With SpondyloarthropathyStatus unknownNCT00517101
• Rituxan With or Without Methotrexate in Psoriatic ArthritisCompletedNCT00509678Phase 1
• Psoriasis Longitudinal Assessment and RegistryActive, not recruitingNCT00508547
• Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug TreatmentCompletedNCT00451243
• Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic ArthritisCompletedNCT00432406Phase 4
• A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)CompletedNCT00427362Phase 3
• Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and PsoriasisCompletedNCT00317499Phase 3
• Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT00235885Phase 3
• Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic ArthritisCompletedNCT00195689Phase 3
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainCompletedNCT00195377
• Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
• TNFalfa Blocking Treatment of SpondylarthropathiesCompletedNCT00133315Phase 4
• Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsCompletedNCT00126724Phase 1/2
• Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
• Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque PsoriasisTerminatedNCT00090129Phase 3
• Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic ArthritisCompletedNCT00051662Phase 1
• A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic ArthritisCompletedNCT00051623Phase 3
• Impact of Literacy Level on Patient Education and Health Among People With ArthritisCompletedNCT00023205Phase 2
• A Controlled Trial of Intermittent Fludarabine for Psoriatic ArthritisCompletedNCT00001422Phase 2
• Study of Psoriatic ArthritisCompletedNCT00001420
• Genetic and Immune Studies of Rheumatoid Arthritis and Related ConditionsCompletedNCT00001291

← Arthritis, Psoriatic overview